PSP Research »

Crinetics Pharmaceuticals In shares owned by PSP Research

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $527k 11k 46.55

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Henderson Group
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In